Phycus Biotechnologies Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Phycus Biotechnologies General Information

Description

Operator of a biotechnology company intended to develop products from biological sources. The company leverages the properties of algae and other aquatic organisms to develop a bioactive compound that can be utilized in cosmetics, dietary supplements, functional foods, and natural pesticides, enabling industries to address the growing demand for natural and eco-friendly options.

Contact Information

Website
www.phycusbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 705 - 555 Richmond Street West
  • Toronto, Ontario M5V 3B1
  • Canada
Primary Industry
Multi-line Chemicals
Other Industries
Environmental Services (B2B)
Vertical(s)
CleanTech, Industrials, Life Sciences
Corporate Office
  • Number 705 - 555 Richmond Street West
  • Toronto, Ontario M5V 3B1
  • Canada

Phycus Biotechnologies Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phycus Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Aug-2026 Completed Generating Revenue
9. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
8. Accelerator/Incubator Completed Startup
7. Later Stage VC 01-Feb-2022 Completed Generating Revenue
6. Grant 13-Jul-2020 Completed Generating Revenue
5. Grant 01-Jan-2020 Completed Startup
4. Grant 09-May-2018 Completed Startup
3. Accelerator/Incubator 01-Jan-2018 Completed Startup
2. Accelerator/Incubator 01-Jan-2017 $37.4K Completed Startup
1. Accelerator/Incubator 01-Jan-2017 $37.4K $37.4K Completed Startup
To view Phycus Biotechnologies’s complete valuation and funding history, request access »

Phycus Biotechnologies Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Phycus Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025245633-A1 Enzymes for the production of glycolic acid and other hydroxycarboxylic acids Pending 30-May-2024
EP-4720321-A1 One-pot fermentative production of glycolate or other hydroxycarboxylic acids Pending 02-Jun-2023
US-20260357306-A1 One-pot fermentative production of glycolate or other hydroxycarboxylic acids Pending 02-Jun-2023
WO-2024243707-A1 One-pot fermentative production of glycolate or other hydroxycarboxylic acids Inactive 02-Jun-2023 C12N15/70

Phycus Biotechnologies Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto University Minority
Bioindustrial Innovation Canada Not-For-Profit Venture Capital Minority
Cycle Capital Management Venture Capital Minority
Impact Chemistry Other Private Equity Minority
Invest Nova Scotia Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Phycus Biotechnologies FAQs

  • When was Phycus Biotechnologies founded?

    Phycus Biotechnologies was founded in 2017.

  • Where is Phycus Biotechnologies headquartered?

    Phycus Biotechnologies is headquartered in Toronto, Canada.

  • What industry is Phycus Biotechnologies in?

    Phycus Biotechnologies’s primary industry is Multi-line Chemicals.

  • Is Phycus Biotechnologies a private or public company?

    Phycus Biotechnologies is a Private company.

  • What is Phycus Biotechnologies’s current revenue?

    The current revenue for Phycus Biotechnologies is .

  • How much funding has Phycus Biotechnologies raised over time?

    Phycus Biotechnologies has raised $77.4K.

  • Who are Phycus Biotechnologies’s investors?

    University of Toronto, Bioindustrial Innovation Canada, Cycle Capital Management, Impact Chemistry, and Invest Nova Scotia are 5 of 9 investors who have invested in Phycus Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process